Key result
M-TEER provides a viable therapeutic option for heart failure patients refractory to CRT.
Key points are not available for this paper at this time.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yasmin et al. (2025) studied this question. Mitral transcatheter edge-to-edge repair (MTEER) was evaluated as a therapeutic option for heart failure patients who are refractory to cardiac resynchronization therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: